Safe, affordable, and scalable automation for NHS pharmacy aseptic units. Protecting staff, improving accuracy, and meeting rising oncology demand.
By 2030, around 13,000 NHS patients may not be able to access chemotherapy due to capacity constraints. The status quo is not sustainable.
Manual chemotherapy preparation exposes staff to hazardous drugs and risks errors due to fatigue and complexity of high-volume compounding.
Increasing oncology demand and workforce shortages add pressure on pharmacy aseptic units to deliver safely and efficiently — with fewer people.
Existing robotic systems are costly, complex, and require extensive infrastructure modifications, limiting adoption across NHS hospitals.
Solutions must be safe, affordable, scalable, and compatible with existing NHS infrastructure to meaningfully improve safety and throughput.
NHS patients may lose access to chemotherapy by 2030 due to capacity constraints — unless pharmacy services are fundamentally rethought.
A compact, intelligent system that fits directly into existing Class II laminar flow hoods — no infrastructure changes, no dedicated spaces, immediate value.
Real-time continuous weighing and RFID/barcode traceability ensures precise, auditable drug preparation every single time.
Installs within existing Class II laminar airflow cabinets and isolators. No major infrastructure changes or service disruptions required.
Supports various drug types, vial formats, syringes, and infusion bags for high-volume oncology pharmacy workflows.
Integrates via HL7 or operates standalone with ChemoPlan software, offering ease of use and rapid staff training.
The system is future-proof and ready to integrate with AI and LLM technologies where applicable, ensuring long-term value.
Meets EU Machinery and EMC Directives, validated under Class II laminar airflow environments to NHS standards.
ChemoMaker+ has already demonstrated its value in real pharmacy environments across Europe, delivering measurable outcomes in safety, efficiency, and cost.
Chemotherapy doses prepared in a single 7-day deployment in Italy
Different drug types compounded successfully in that same 7-day period
Residual drug savings generated from a total drug value of €219,345
Preparations achievable per hour with a single operator per machine
Not a procurement commitment — a structured 12-week evaluation embedded in real NHS workflows, fully supported and at no cost.
A 12-week early adopter evaluation, fully embedded in real NHS workflows. Not a big procurement decision — a chance to see it work for yourself.
Safety, efficiency, workforce impact, and cost are all tracked and measured throughout the evaluation period with full transparency.
Make your decision based on real evidence, not theory. And critically, there is no cost during the evaluation period.
Supported by Health Innovation East Midlands, working in partnership with NHS Trusts, pharmacy leaders, and integrated care systems.
The question isn't "Should we adopt automation?" It's "Why would we keep guessing when we can actually test it?"
Stop asking people to work harder. Start designing systems that work smarter.
Contact GMG to register your Trust's interest
We assess your current pharmacy setup
Live deployment with full measurement
Review outcomes and decide on next steps